<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.7.31">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">

<meta name="author" content="Russell E. Lewis">
<meta name="author" content="Dimitrios P. Kontoyiannis">
<meta name="keywords" content="Liposomal amphotericin B, invasive mucormycosis, pharmacokinetics/pharmacodynamics">

<title>Does evidence support high-dose liposomal amphotericin B in the treatment of mucormycosis?</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
/* CSS for citations */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging-indent div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}</style>


<script src="HD_Ambi_files/libs/clipboard/clipboard.min.js"></script>
<script src="HD_Ambi_files/libs/quarto-html/quarto.js" type="module"></script>
<script src="HD_Ambi_files/libs/quarto-html/tabsets/tabsets.js" type="module"></script>
<script src="HD_Ambi_files/libs/quarto-html/popper.min.js"></script>
<script src="HD_Ambi_files/libs/quarto-html/tippy.umd.min.js"></script>
<script src="HD_Ambi_files/libs/quarto-html/anchor.min.js"></script>
<link href="HD_Ambi_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="HD_Ambi_files/libs/quarto-html/quarto-syntax-highlighting-e1a5c8363afafaef2c763b6775fbf3ca.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="HD_Ambi_files/libs/bootstrap/bootstrap.min.js"></script>
<link href="HD_Ambi_files/libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="HD_Ambi_files/libs/bootstrap/bootstrap-bb462d781dde1847d9e3ccf7736099dd.min.css" rel="stylesheet" append-hash="true" id="quarto-bootstrap" data-mode="light">


</head>

<body class="fullcontent quarto-light">

<div id="quarto-content" class="page-columns page-rows-contents page-layout-article">

<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title">Does evidence support high-dose liposomal amphotericin B in the treatment of mucormycosis?</h1>
</div>


<div class="quarto-title-meta-author">
  <div class="quarto-title-meta-heading">Authors</div>
  <div class="quarto-title-meta-heading">Affiliations</div>
  
    <div class="quarto-title-meta-contents">
    <p class="author">Russell E. Lewis <a href="mailto:russelledward.lewis@unipd.it" class="quarto-title-author-email"><i class="bi bi-envelope"></i></a> </p>
  </div>
  <div class="quarto-title-meta-contents">
        <p class="affiliation">
            University of Padua
          </p>
      </div>
    <div class="quarto-title-meta-contents">
    <p class="author">Dimitrios P. Kontoyiannis <a href="mailto:dkontoyi@mdanderson.org" class="quarto-title-author-email"><i class="bi bi-envelope"></i></a> </p>
  </div>
  <div class="quarto-title-meta-contents">
        <p class="affiliation">
            The University of Texas M.D.&nbsp;Anderson Cancer Center
          </p>
      </div>
  </div>

<div class="quarto-title-meta">

      
  
    
  </div>
  
<div>
  <div class="abstract">
    <div class="block-title">Abstract</div>
    <p>Introduction, Areas covered:, Expert opionion:</p>
  </div>
</div>

<div>
  <div class="keywords">
    <div class="block-title">Keywords</div>
    <p>Liposomal amphotericin B, invasive mucormycosis, pharmacokinetics/pharmacodynamics</p>
  </div>
</div>

</header>


<section id="introduction" class="level1">
<h1>Introduction</h1>
<p>Invasive mucormycosis, caused primarily by <em>Rhizopus, Mucor, and Lichtheimia</em> species of the order Mucorales, is a life-threatening fungal infection that has increased in incidence over the past two decades, predominantly affecting immunocompromised patients with hematologic malignancies, solid organ or hematopoietic cell transplantation, and poorly controlled diabetes mellitus <span class="citation" data-cites="skiada2025a">[<a href="#ref-skiada2025a" role="doc-biblioref">1</a>]</span> . Characterized by aggressive angioinvasion and tissue necrosis, mucormycosis carries mortality rates of 40-80% depending on infection site, diagnostic and treatment delays, feasibility of surgical debridement, and host immune recovery <span class="citation" data-cites="sigera2023b jeong2019d jeong2015 jeong2019e">[<a href="#ref-sigera2023b" role="doc-biblioref">2</a>–<a href="#ref-jeong2019e" role="doc-biblioref">5</a>]</span>. Current guidelines recommend initial therapy with intravenous liposomal amphot<span class="citation" data-cites="lewandowska2021a">[<a href="#ref-lewandowska2021a" role="doc-biblioref">6</a>]</span>ericin B (L-AMB) until clinical stabilization, followed by step-down to posaconazole or isavuconazole <span class="citation" data-cites="cornely2019a">[<a href="#ref-cornely2019a" role="doc-biblioref">7</a>]</span>.</p>
<p>Due to the aggressiveness of the infection, higher L-AMB doses (&gt;5 mg/kg/day) are frequently recommended during the acute treatment phase of infection to rapidly load infected tissue to limit fungal invasion and dissemination <span class="citation" data-cites="lewis2012a">[<a href="#ref-lewis2012a" role="doc-biblioref">8</a>]</span>. While experimental animal models demonstrate a clear dose-response relationship for L-AMB <span class="citation" data-cites="lewis2010a">[<a href="#ref-lewis2010a" role="doc-biblioref">9</a>]</span>, &nbsp;prospective trials <span class="citation" data-cites="lanternier2015a spellberg2011a">[<a href="#ref-lanternier2015a" role="doc-biblioref">10</a>,<a href="#ref-spellberg2011a" role="doc-biblioref">11</a>]</span> and observational studies <span class="citation" data-cites="tashiro2023a jestin2021a risum2020a">[<a href="#ref-tashiro2023a" role="doc-biblioref">12</a>–<a href="#ref-risum2020a" role="doc-biblioref">14</a>]</span> have not confirmed improved outcomes with higher L-AMB dosing. Indeed, the <em>Global Guidelines for the Diagnosis and Management of Mucormycosis</em> developed by the European Confederation of Medical Mycology (ECMM)/Mycoses Study Group Education and Research Consortium (MSGERC) recommend a broad initial dosing range for liposomal amphotericin B of 5-10 mg/kg/day <span class="citation" data-cites="cornely2019b">[<a href="#ref-cornely2019b" role="doc-biblioref">15</a>]</span>.</p>
<p>Uncertainty regarding the optimal dosing of L-AMB is clinically important as higher doses often carry increased risks of nephrotoxicity and infusion-related as well as higher drug costs <span class="citation" data-cites="jeong2019c">[<a href="#ref-jeong2019c" role="doc-biblioref">16</a>]</span>. In this review, we critically evaluate the pharmacokinetic, preclinical, and clinical evidence supporting dose escalation, examine patient-specific factors that may influence the benefit-risk ratio of high-dose L-AMB therapy for mucormycosis, and provide practical recommendations for individualizing dosing of this essential antifungal medication.</p>
</section>
<section id="pharmacodynamics-of-liposomal-amphotericin-b" class="level1">
<h1>Pharmacodynamics of liposomal amphotericin B</h1>
<p>Amphotericin B (AMB) is a polyene macrolide antifungal agent with broad-spectrum activity against most clinically relevant fungi. Its amphiphilic structure renders it insoluble in body fluids at a neutral pH. The primary mechanism of antifungal action has long thought to involve binding to ergosterol in fungal cell membranes, forming transmembrane channels that disrupt membrane integrity and cause lethal ion leakage, particularly of potassium. However, more recent studies using solid-state NMR suggest amphotericin B forms extramembrane aggregates or “sponges” that extract ergosterol from the fungal cell wall <span class="citation" data-cites="anderson2014a lewandowska2021b">[<a href="#ref-anderson2014a" role="doc-biblioref">17</a>,<a href="#ref-lewandowska2021b" role="doc-biblioref">18</a>]</span>. When incorporated into a liposome, the polyene remains inside the liposome carrier until drug is released when the liposome comes in contact with ergosterol in teh fungal cell membrane<span class="citation" data-cites="walker2018">[<a href="#ref-walker2018" role="doc-biblioref">19</a>]</span>.</p>
<p>Clinical use of liposomal formulation is associated with fewer delayed (2-6 hour) infusion-related reactions mediated by proinflamamtory cytokine (e.g., Interleukin (IL-1ß, IL-6, IL-8 and prostaglandin E<sub>2</sub>) release, although an immediate unique type-1 hypersensitivity reaction termed “complement activation-related pseudoallergy” (CARPA) can arise from infusion of the liposomes <span class="citation" data-cites="szebeni2005">[<a href="#ref-szebeni2005" role="doc-biblioref">20</a>]</span>. Amphotericin B-associated nephrotoxicity, which arises through direct constriction of renal arterioles and direct damage to the distal tubular membranes resulting in loss of potassium and bicarbonate, is reduced with the liposomal formulation due to the preferential distribution of the drug to organs rich in reticuloendothelial cells and lack of glomerular filtration of the liposome carrier <span class="citation" data-cites="adler-moore2019">[<a href="#ref-adler-moore2019" role="doc-biblioref">21</a>]</span>.</p>
<p>Amphotericin B exhibits concentration-dependent killing and prolonged post-antifungal effects in yeast and molds, with antifungal effects linked to the C<sub>max</sub>/MIC and AUC<sub>0-24</sub>/MIC- thus supporting the concept that &nbsp;higher, infrequently administered dosing regimens will exhibit better antifungal efficacy <span class="citation" data-cites="andes2001a wiederhold2006a andes2006">[<a href="#ref-andes2001a" role="doc-biblioref">22</a>–<a href="#ref-andes2006" role="doc-biblioref">24</a>]</span>. In neutropenic and rabbit models of aspergillosis, near-maximal antifungal efficacy is observed when the total serum amphotericin B concentrations C<sub>max</sub>/MIC surpasses 2.5 or and AUC<sub>0-24</sub>/MIC of 13.6 <span class="citation" data-cites="al-nakeeb2015">[<a href="#ref-al-nakeeb2015" role="doc-biblioref">25</a>]</span>. However, encapsulation of amphotericin B in the unilamellar liposomes changes the pharmacokinetics and pharmacodynamics of the drug, reducing drug interactions with mammalian cell membranes while enhancing tissue distribution and reducing toxicity compared with conventional amphotericin B deoxycholate <span class="citation" data-cites="groll2019a">[<a href="#ref-groll2019a" role="doc-biblioref">26</a>]</span>. Hence, the liposome carrier confounds the PK/PD relationship between serum drug concentrations, which contain both non biologically active drug encased inside liposomes and free drug, versus biological activity observed in infected tissue.</p>
<p>Few studies have explored the pharmacodynamics of escalating L-AMB doses in animal models of mucormycosis. Using a neutropenic mouse model of pulmonary mucormycosis, Lewis et al. <span class="citation" data-cites="lewis2010b">[<a href="#ref-lewis2010b" role="doc-biblioref">27</a>]</span> reported improved clearance of <em>R. oryzae</em> lung fungal burden as daily intravenous doses of L-AMB increased from 5 mg/kg to 10 mg/kg daily. Fungal clearance correlated with lung tissue homogenate concentrations of AMB surpassing the mean fungicidal concentration (MFC) of the <em>R. oryzae</em> isolate (8 mg/L) inoculated in animals. Interestingly, total lung concentrations of amphotericin B decreased after 72 hours as fungal burden declined despite sustained 10 mg/kg/day dosing, suggesting either saturation of drug accumulation in the lung or decreased distribution of the liposomes to the lung with fungal clearance.</p>
<p>Studies using diabetic ketoacidosis and pulmonary mucormycosis infection models by the Ibrahim research group at UCLA <span class="citation" data-cites="ibrahim2008 gebremariam2022 gu2023 luo2013">[<a href="#ref-ibrahim2008" role="doc-biblioref">28</a>–<a href="#ref-luo2013" role="doc-biblioref">31</a>]</span> and Takemoto et al. <span class="citation" data-cites="takemoto2010">[<a href="#ref-takemoto2010" role="doc-biblioref">32</a>]</span> confirmed that L-AMB doses ≥10 mg/kg/day achieve superior tissue fungal clearance compared to lower doses, particularly in the central nervous system. In a review of L-AMB tissue penetration data from animal models, Adler-Moore et al.&nbsp;confirmed &nbsp;accumulation of L-AMB increases in a dose-dependent manner <span class="citation" data-cites="adler-moore2017">[<a href="#ref-adler-moore2017" role="doc-biblioref">33</a>]</span>. However, the dose-response relationship varies by organ, exhibiting linear kinetics in some tissues and non-linear kinetics in others, influenced by both animal species and infection status. The liver and spleen consistently show the highest drug retention across all animal infection models.</p>
</section>
<section id="human-pharmacokinetics" class="level1">
<h1>Human pharmacokinetics</h1>
<p>Following intravenous administration, liposomal amphotericin B (L-AMB) maintains its physicochemical integrity over extended periods, resulting in prolonged residence time within the central compartment <a href="#fig-distribution" class="quarto-xref">Figure&nbsp;1</a>.</p>
<div id="fig-distribution" class="quarto-float quarto-figure quarto-figure-center anchored" data-fig-align="center">
<figure class="quarto-float quarto-float-fig figure">
<div aria-describedby="fig-distribution-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<img src="L-AMB_distr.png" class="img-fluid quarto-figure quarto-figure-center figure-img" width="800">
</div>
<figcaption class="quarto-float-caption-bottom quarto-float-caption quarto-float-fig" id="fig-distribution-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Figure&nbsp;1: Pharmacokinetic model of liposomal amphotericin B. Following intravenous administration, liposomal amphotericin B distributes from the central compartment (1, plasma) to reticuloendothelial system organs including the liver, spleen, and bone marrow (compartment 2), and to kidney, lung and other peripheral tissues (compartment 3). Rate constants (<em>k</em>) indicate bidirectional transfer between compartments: <em>k12</em> and <em>k21</em> represent distribution and redistribution between plasma and reticuloendothelial organs; <em>k13</em> and <em>k31</em> between plasma and peripheral tissues; and <em>k23</em> and <em>k32</em> between reticuloendothelial organs and peripheral tissues. Drug elimination occurs from the central compartment via biliary and urinary excretion (dotted arrow). Figure adapted from Groll et al <span class="citation" data-cites="groll2019c">[<a href="#ref-groll2019c" role="doc-biblioref">34</a>]</span>.
</figcaption>
</figure>
</div>
<p>The drug exhibits non-linear pharmacokinetics with substantial interpatient pharmacokinetic variability across therapeutic doses. At doses of 1.0, 2.5, 5.0, and 7.5 mg/kg, first-day mean AUCs increased disproportionally (32, 71, 294, and 534 µg·h/mL, respectively) <a href="#tbl-pk" class="quarto-xref">Table&nbsp;1</a>. Concurrently, mean plasma clearance declined at higher doses, decreasing from 39-51 mL/h/kg at 1.0-2.5 mg/kg/day to 21-25 mL/h/kg at 5.0-7.5 mg/kg/day <span class="citation" data-cites="walsh1998">[<a href="#ref-walsh1998" role="doc-biblioref">35</a>]</span>.</p>
<div id="tbl-pk" class="quarto-float quarto-figure quarto-figure-center anchored">
<figure class="quarto-float quarto-float-tbl figure">
<figcaption class="quarto-float-caption-top quarto-float-caption quarto-float-tbl" id="tbl-pk-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Table&nbsp;1: Pharmacokinetic and pharmacodynamic properties of liposomal amphotericin B. <sup>a</sup>Data are from reference <span class="citation" data-cites="bekersky2002a">[<a href="#ref-bekersky2002a" role="doc-biblioref">36</a>]</span> ; <sup>b</sup>Data are from reference <span class="citation" data-cites="bekersky2002">[<a href="#ref-bekersky2002" role="doc-biblioref">37</a>]</span> ; <sup>c</sup> Data are from reference <span class="citation" data-cites="walsh2001a">[<a href="#ref-walsh2001a" role="doc-biblioref">38</a>]</span>
</figcaption>
<div aria-describedby="tbl-pk-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<table class="caption-top table">
<colgroup>
<col style="width: 50%">
<col style="width: 50%">
</colgroup>
<thead>
<tr class="header">
<th style="text-align: left;">Characteristic</th>
<th style="text-align: left;"></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td style="text-align: left;">Formulation</td>
<td style="text-align: left;">Small (60-80 nm) unilamellar liposomes consisting of distearoyl phosphatidylglycerol, cholesterol, and hydrogenated soy phosphatidylcholine; in a 2:1:0.8 molar ratio and AmB in a 9:1 lipid:drug molar ratio</td>
</tr>
<tr class="even">
<td style="text-align: left;">Pharmacodynamics</td>
<td style="text-align: left;">C<sub>max</sub>/MIC, AUC/MIC</td>
</tr>
<tr class="odd">
<td style="text-align: left;">Free (non-liposomal bound drug) in plasma<sup>a</sup></td>
<td style="text-align: left;">&lt;25 ng/mL</td>
</tr>
<tr class="even">
<td style="text-align: left;">Mean C<sub>max</sub> mg/L<sup>b</sup></td>
<td style="text-align: left;">58</td>
</tr>
<tr class="odd">
<td style="text-align: left;">Mean AUC<sub>0-24h</sub> mg/Lxh<sup>b</sup></td>
<td style="text-align: left;">713</td>
</tr>
<tr class="even">
<td style="text-align: left;">Mean CL<sub>t</sub> L/h/kg<sup>b</sup></td>
<td style="text-align: left;">0.017</td>
</tr>
<tr class="odd">
<td style="text-align: left;">Dose linearity<sup>c</sup></td>
<td style="text-align: left;">Up to 10 mg/kg/day in adults</td>
</tr>
<tr class="even">
<td style="text-align: left;">Metabolism</td>
<td style="text-align: left;">Not metabolized</td>
</tr>
<tr class="odd">
<td style="text-align: left;">Elimination</td>
<td style="text-align: left;">Unchanged feces and urine (&lt; 10% over one week)</td>
</tr>
<tr class="even">
<td style="text-align: left;">Dosage adjustment in renal impairment</td>
<td style="text-align: left;">No adjustment for accumulation concerns</td>
</tr>
<tr class="odd">
<td style="text-align: left;">Dosage adjustment in hepatic impairment</td>
<td style="text-align: left;">No adjustment for accumulation concerns</td>
</tr>
</tbody>
</table>
</div>
</figure>
</div>
<p>This non-linear behaviour becomes more pronounced with further dose escalation. A subsequent Phase I/II trial evaluating 10, 12.5, and 15 mg/kg/day L-AMB in patients with invasive mold infections reported mean AUC and C<sub>max</sub> values plateaued at 10 mg/kg/day and paradoxically declined at doses of 12.5 and 15 mg/kg/day, indicating saturable distribution or elimination pathways <span class="citation" data-cites="walsh2001">[<a href="#ref-walsh2001" role="doc-biblioref">39</a>]</span>. Therefore, it is unclear whether L-AMB daily dosages exceeding 10 mg/kg distribute more drug to target organs such as the lung, sinuses or brain, which are the most frequent sites of infection in invasive mucormycosis.</p>
</section>
<section id="clinical-studies" class="level1">
<h1>Clinical studies</h1>
<p>Several observational studies and one prospective pilot study evaluated clinical outcomes follwing administration of HD L-AMB <a href="#tbl-clinical" class="quarto-xref">Table&nbsp;2</a>. The most informative trial was the AmBizygo trial, which prospectively evaluated high-dose liposomal amphotericin B (10 mg/kg/day) for 4 weeks in 34 patients with mucormycosis, with 71% undergoing surgical debridement <span class="citation" data-cites="lanternier2015c">[<a href="#ref-lanternier2015c" role="doc-biblioref">40</a>]</span>. The overall response rate was 36% at week 4 and 45% at week 12, with mortality rates of 38% and 53% at weeks 12 and 24, respectively. Creatinine doubling occurred in 40% of patients, though renal dysfunction was reversible in 63% within 3 months. This study demonstrated that high-dose L-AMB combined with surgery achieved response rates comparable to or better than other first-line therapies, despite increased but manageable nephrotoxicity.</p>
<p>Other observational studies</p>
<div id="tbl-clinical" class="quarto-float quarto-figure quarto-figure-center anchored">
<figure class="quarto-float quarto-float-tbl figure">
<figcaption class="quarto-float-caption-top quarto-float-caption quarto-float-tbl" id="tbl-clinical-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Table&nbsp;2: Clinical studies evaluting high-dose liposomal amphotericin B for mucormycosis
</figcaption>
<div aria-describedby="tbl-clinical-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<table class="caption-top table">
<colgroup>
<col style="width: 25%">
<col style="width: 25%">
<col style="width: 25%">
<col style="width: 25%">
</colgroup>
<thead>
<tr class="header">
<th style="text-align: left;">Author- year</th>
<th style="text-align: left;">Study design</th>
<th style="text-align: left;">L-AMB treatment regimen</th>
<th style="text-align: left;">Outcomes</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td style="text-align: left;">Lanternier et al.&nbsp;2015 <span class="citation" data-cites="lanternier2015b">[<a href="#ref-lanternier2015b" role="doc-biblioref">41</a>]</span></td>
<td style="text-align: left;">Prospective, multicenter pilot study; <br>n=40 patients;<br>most hematologic malignancy, 33% neutropenic</td>
<td style="text-align: left;">10 mg/kg/day for median of 13.5 days (range 0-28)</td>
<td style="text-align: left;">Response rate (n=33 patients at week 4) <br>38% overall mortality at week 12 and 53% at week 24 <br> SeCr doubling in 40% of patients</td>
</tr>
<tr class="even">
<td style="text-align: left;">Valiante et al.&nbsp;2023 <span class="citation" data-cites="valiante2023a">[<a href="#ref-valiante2023a" role="doc-biblioref">42</a>]</span></td>
<td style="text-align: left;">Retrospective cohort study; <br> (n=67 adults with probable/proven mucormycosis <br></td>
<td style="text-align: left;">L-AMB &lt; 6 mg/kg/dayvs. ≥ 6 mg/kg/day</td>
<td style="text-align: left;">12-week mortality rate 49 vs.&nbsp;50% <br> Similar rates of acute kidney injury (47% v.s 50%)</td>
</tr>
<tr class="odd">
<td style="text-align: left;">Tashiro et al.&nbsp;2023 <span class="citation" data-cites="tashiro2023b">[<a href="#ref-tashiro2023b" role="doc-biblioref">43</a>]</span></td>
<td style="text-align: left;">Retrospective multicenter nationwide cohort analysis <br> n=82 cases</td>
<td style="text-align: left;">L-AMB 5 mg/kg/day vs.&nbsp;≥ 5 mg/kg/day</td>
<td style="text-align: left;">Survival did not differ between patients receiving liposomal amphotericin B at 5 mg/kg/d relative to those receiving &gt;5 mg/kg/d (P = .625). <br>Using Cox proportional hazards models and adjusting for confounders, the hazard ratio for the influence of &gt;5 mg/kg/d liposomal amphotericin B on 4-week survival was 0.86 (95% CI, 0.28–2.68; P = .796) compared with 5 mg/kg/d.</td>
</tr>
<tr class="even">
<td style="text-align: left;">Stover et al.&nbsp;2024 <span class="citation" data-cites="stover2024">[<a href="#ref-stover2024" role="doc-biblioref">44</a>]</span></td>
<td style="text-align: left;">Single-center case series, mixed population</td>
<td style="text-align: left;">L-AMB mean 8.9 mg/kg/day for 11 days</td>
<td style="text-align: left;">Response rate 33% <br> one-third of patients developed doubling baseline serum creatine</td>
</tr>
<tr class="odd">
<td style="text-align: left;">Jeong et al.&nbsp;2019 <span class="citation" data-cites="jeong2019f">[<a href="#ref-jeong2019f" role="doc-biblioref">45</a>]</span></td>
<td style="text-align: left;">Systematic review of 851 published cases, mixed population</td>
<td style="text-align: left;">n=57 received high-dose L-AMB (6–15 mg/kg/day)</td>
<td style="text-align: left;">Compared with patients receiving 5 mg/kg/day of i.v. L-AmB, those who received higher doses had a higher 90-day mortality, although not statistically significant [22/57 (38.6%) vs.&nbsp;29/93 (31.2%); P = 0.352]. In addition, renal toxicity was more common following administration of higher-dose i.v. L-AmB [15/57 (26.3%) vs.&nbsp;12/93 (12.9%); P = 0.038</td>
</tr>
<tr class="even">
<td style="text-align: left;">Elitzuer et al.&nbsp;2021 <span class="citation" data-cites="elitzur2021a">[<a href="#ref-elitzur2021a" role="doc-biblioref">46</a>]</span></td>
<td style="text-align: left;">Retrospective analysis of 12 pediatric cases, mixed posultion</td>
<td style="text-align: left;">N=5/12 (42%) received HD L-AMB during treatment <br> only 1/5 (20%) as monotherapy</td>
<td style="text-align: left;">4/5 (80%) of patients survived with HD L-AMB vs.&nbsp;4/5 died with standard dose of L-AMB (3/5 in combination with triazole or echinocandin)</td>
</tr>
<tr class="odd">
<td style="text-align: left;">Risum et al.&nbsp;2020 <span class="citation" data-cites="risum2020b">[<a href="#ref-risum2020b" role="doc-biblioref">47</a>]</span></td>
<td style="text-align: left;">Retrospective analysis of 13 patients with invasive mucormycosis</td>
<td style="text-align: left;">3/13 received HD L-AMB for suspected CNS involvement in combination with other antifungals</td>
<td style="text-align: left;">3/3 response (100%) with HD-L-AMB vs.&nbsp;10/13 standard dose (77%)</td>
</tr>
</tbody>
</table>
</div>
</figure>
</div>
</section>
<section id="future-implications" class="level1">
<h1>Future implications</h1>
</section>
<section id="plain-language-summary" class="level1">
<h1>Plain language summary</h1>
</section>
<section id="references" class="level1 unnumbered">


</section>

<div id="quarto-appendix" class="default"><section class="quarto-appendix-contents" role="doc-bibliography" id="quarto-bibliography"><h2 class="anchored quarto-appendix-heading">References</h2><div id="refs" class="references csl-bib-body" role="list">
<div id="ref-skiada2025a" class="csl-entry" role="listitem">
<div class="csl-left-margin">[1] </div><div class="csl-right-inline">Skiada A, Drogari-Apiranthitou M, Roilides E, et al. <a href="https://doi.org/10.1007/s11046-025-00954-6">A Global Analysis of Cases of Mucormycosis Recorded in the European Confederation of Medical Mycology / International Society for Human and Animal Mycology (ECMM / ISHAM) Zygomyco.net Registry from 2009 to 2022</a>. Mycopathologia [Internet]. 2025;190(4):53.</div>
</div>
<div id="ref-sigera2023b" class="csl-entry" role="listitem">
<div class="csl-left-margin">[2] </div><div class="csl-right-inline">Sigera LSM, Denning DW. <a href="https://doi.org/10.1093/ofid/ofad704">A Systematic Review of the Therapeutic Outcome of Mucormycosis</a>. Open Forum Infectious Diseases [Internet]. 2023;11(1).</div>
</div>
<div id="ref-jeong2019d" class="csl-entry" role="listitem">
<div class="csl-left-margin">[3] </div><div class="csl-right-inline">Jeong W, Keighley C, Wolfe R, et al. <a href="https://doi.org/10.1016/j.ijantimicag.2019.01.002">Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports</a>. International Journal of Antimicrobial Agents [Internet]. 2019;53(5):589–597.</div>
</div>
<div id="ref-jeong2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">[4] </div><div class="csl-right-inline">Jeong SJ, Lee JU, Song YG, et al. <a href="https://doi.org/10.1111/myc.12428">Delaying diagnostic procedure significantly increases mortality in patients with invasive mucormycosis</a>. Mycoses [Internet]. 2015;58(12):746752.</div>
</div>
<div id="ref-jeong2019e" class="csl-entry" role="listitem">
<div class="csl-left-margin">[5] </div><div class="csl-right-inline">Jeong W, Keighley C, Wolfe R, et al. <a href="https://doi.org/10.1016/j.ijantimicag.2019.01.002">Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports</a>. International Journal of Antimicrobial Agents [Internet]. 2019;53(5):589–597.</div>
</div>
<div id="ref-lewandowska2021a" class="csl-entry" role="listitem">
<div class="csl-left-margin">[6] </div><div class="csl-right-inline">Lewandowska A, Soutar CP, Greenwood AI, et al. <a href="https://doi.org/10.1038/s41594-021-00685-4">Fungicidal amphotericin B sponges are assemblies of staggered asymmetric homodimers encasing large void volumes</a>. Nature Structural &amp; Molecular Biology. 2021;28(12):972–981.</div>
</div>
<div id="ref-cornely2019a" class="csl-entry" role="listitem">
<div class="csl-left-margin">[7] </div><div class="csl-right-inline">Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. <a href="https://doi.org/10.1016/S1473-3099(19)30312-3">Global guideline for the diagnosis and management of mucormycosis: An initiative of the european confederation of medical mycology in cooperation with the mycoses study group education and research consortium</a>. The Lancet Infectious Diseases [Internet]. 2019;19(12):e405 e421.</div>
</div>
<div id="ref-lewis2012a" class="csl-entry" role="listitem">
<div class="csl-left-margin">[8] </div><div class="csl-right-inline">Lewis RE, Lortholary O, Spellberg B, et al. <a href="https://doi.org/10.1093/cid/cir884">How does antifungal pharmacology differ for mucormycosis versus aspergillosis?</a> Clinical Infectious Diseases [Internet]. 2012;54(SUPPL. 1):S67–S72.</div>
</div>
<div id="ref-lewis2010a" class="csl-entry" role="listitem">
<div class="csl-left-margin">[9] </div><div class="csl-right-inline">Lewis RE, Albert ND, Liao G, et al. <a href="https://doi.org/10.1128/AAC.01222-09">Comparative pharmacodynamics of amphotericin b lipid complex and liposomal amphotericin b in a murine model of pulmonary mucormycosis</a>. Antimicrobial Agents and Chemotherapy [Internet]. 2010;54(3):1298–1304.</div>
</div>
<div id="ref-lanternier2015a" class="csl-entry" role="listitem">
<div class="csl-left-margin">[10] </div><div class="csl-right-inline">Lanternier F, Poiree S, Elie C, et al. <a href="https://doi.org/10.1093/jac/dkv236">Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis</a>. Journal of Antimicrobial Chemotherapy [Internet]. 2015;70(11):3116–3123.</div>
</div>
<div id="ref-spellberg2011a" class="csl-entry" role="listitem">
<div class="csl-left-margin">[11] </div><div class="csl-right-inline">Spellberg B, Ibrahim AS, Chin-Hong PV, et al. <a href="https://doi.org/10.1093/jac/dkr375">The Deferasirox<span></span>AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial</a>. Journal of Antimicrobial Chemotherapy [Internet]. 2011;67(3):715–722.</div>
</div>
<div id="ref-tashiro2023a" class="csl-entry" role="listitem">
<div class="csl-left-margin">[12] </div><div class="csl-right-inline">Tashiro M, Namie H, Ito Y, et al. <a href="https://doi.org/10.1093/ofid/ofad480">Prognostic Association of Liposomal Amphotericin B Doses Above 5<span></span>mg/kg/d in Mucormycosis: A Nationwide Epidemiologic and Treatment Analysis in Japan</a>. Open Forum Infectious Diseases [Internet]. 2023;10(10).</div>
</div>
<div id="ref-jestin2021a" class="csl-entry" role="listitem">
<div class="csl-left-margin">[13] </div><div class="csl-right-inline">Jestin M, Azoulay E, Pène F, et al. <a href="https://doi.org/10.1186/s13613-021-00818-4">Poor outcome associated with mucormycosis in critically ill hematological patients: results of a multicenter study</a>. Annals of Intensive Care [Internet]. 2021;11(1).</div>
</div>
<div id="ref-risum2020a" class="csl-entry" role="listitem">
<div class="csl-left-margin">[14] </div><div class="csl-right-inline">Risum M, Helweg-Larsen J, Petersen SL, et al. <a href="https://doi.org/10.3390/jof6040268">Introduction of a Comprehensive Diagnostic and Interdisciplinary Management Approach in Haematological Patients with Mucormycosis: A Pre and Post-Intervention Analysis</a>. Journal of Fungi [Internet]. 2020;6(4):268.</div>
</div>
<div id="ref-cornely2019b" class="csl-entry" role="listitem">
<div class="csl-left-margin">[15] </div><div class="csl-right-inline">Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. <a href="https://doi.org/10.1016/S1473-3099(19)30312-3">Global guideline for the diagnosis and management of mucormycosis: An initiative of the european confederation of medical mycology in cooperation with the mycoses study group education and research consortium</a>. The Lancet Infectious Diseases [Internet]. 2019;19(12):e405 e421.</div>
</div>
<div id="ref-jeong2019c" class="csl-entry" role="listitem">
<div class="csl-left-margin">[16] </div><div class="csl-right-inline">Jeong W, Keighley C, Wolfe R, et al. <a href="https://doi.org/10.1016/j.ijantimicag.2019.01.002">Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports</a>. International Journal of Antimicrobial Agents [Internet]. 2019;53(5):589–597.</div>
</div>
<div id="ref-anderson2014a" class="csl-entry" role="listitem">
<div class="csl-left-margin">[17] </div><div class="csl-right-inline">Anderson TM, Clay MC, Cioffi AG, et al. <a href="https://doi.org/10.1038/nchembio.1496">Amphotericin forms an extramembranous and fungicidal sterol sponge</a>. Nature Chemical Biology. 2014;10(5):400–406.</div>
</div>
<div id="ref-lewandowska2021b" class="csl-entry" role="listitem">
<div class="csl-left-margin">[18] </div><div class="csl-right-inline">Lewandowska A, Soutar CP, Greenwood AI, et al. <a href="https://doi.org/10.1038/s41594-021-00685-4">Fungicidal amphotericin B sponges are assemblies of staggered asymmetric homodimers encasing large void volumes</a>. Nature Structural &amp; Molecular Biology. 2021;28(12):972–981.</div>
</div>
<div id="ref-walker2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">[19] </div><div class="csl-right-inline">Walker L, Sood P, Lenardon MD, et al. <a href="https://doi.org/10.1128/mBio.02383-17">The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles</a>. mBio [Internet]. 2018;9(1).</div>
</div>
<div id="ref-szebeni2005" class="csl-entry" role="listitem">
<div class="csl-left-margin">[20] </div><div class="csl-right-inline">Szebeni J. <a href="https://doi.org/10.1016/j.tox.2005.07.023">Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity</a>. Toxicology [Internet]. 2005;216(2-3):106121.</div>
</div>
<div id="ref-adler-moore2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">[21] </div><div class="csl-right-inline">Adler-Moore J, Lewis RE, Brüggemann RJM, et al. <a href="https://doi.org/10.1093/cid/ciz064">Preclinical safety, tolerability, pharmacokinetics, pharmacodynamics, and antifungal activity of liposomal amphotericin b</a>. Clinical Infectious Diseases [Internet]. 2019;68:S244 S259.</div>
</div>
<div id="ref-andes2001a" class="csl-entry" role="listitem">
<div class="csl-left-margin">[22] </div><div class="csl-right-inline">Andes D, Stamsted T, Conklin R. <a href="https://doi.org/10.1128/AAC.45.3.922-926.2001">Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model</a>. Antimicrobial agents and chemotherapy [Internet]. 2001;45(3):922926.</div>
</div>
<div id="ref-wiederhold2006a" class="csl-entry" role="listitem">
<div class="csl-left-margin">[23] </div><div class="csl-right-inline">Wiederhold NP, Tam VH, Chi J, et al. <a href="https://doi.org/10.1128/AAC.50.2.469-473.2006">Pharmacodynamic activity of amphotericin b deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis</a>. Antimicrobial Agents and Chemotherapy. 2006;50(2):469473.</div>
</div>
<div id="ref-andes2006" class="csl-entry" role="listitem">
<div class="csl-left-margin">[24] </div><div class="csl-right-inline">Andes D, Safdar N, Marchillo K, et al. <a href="https://doi.org/10.1128/AAC.50.2.674-684.2006">Pharmacokinetic-pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models</a>. Antimicrobial agents and chemotherapy [Internet]. 2006;50(2):674684.</div>
</div>
<div id="ref-al-nakeeb2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">[25] </div><div class="csl-right-inline">Al-Nakeeb Z, Petraitis V, Goodwin J, et al. <a href="https://doi.org/10.1128/AAC.04723-14">Pharmacodynamics of amphotericin B deoxycholate, amphotericin B lipid complex, and liposomal amphotericin B against Aspergillus fumigatus</a>. Antimicrobial agents and chemotherapy [Internet]. 2015;59(5):27352745.</div>
</div>
<div id="ref-groll2019a" class="csl-entry" role="listitem">
<div class="csl-left-margin">[26] </div><div class="csl-right-inline">Groll AH, Rijnders BJA, Walsh TJ, et al. <a href="https://doi.org/10.1093/cid/ciz076">Clinical pharmacokinetics, pharmacodynamics, safety and efficacy of liposomal amphotericin b</a>. Clinical Infectious Diseases [Internet]. 2019;68(Supplement<span>_</span>4):S260–S274.</div>
</div>
<div id="ref-lewis2010b" class="csl-entry" role="listitem">
<div class="csl-left-margin">[27] </div><div class="csl-right-inline">Lewis RE, Albert ND, Liao G, et al. <a href="https://doi.org/10.1128/AAC.01222-09">Comparative pharmacodynamics of amphotericin b lipid complex and liposomal amphotericin b in a murine model of pulmonary mucormycosis</a>. Antimicrobial Agents and Chemotherapy [Internet]. 2010;54(3):1298–1304.</div>
</div>
<div id="ref-ibrahim2008" class="csl-entry" role="listitem">
<div class="csl-left-margin">[28] </div><div class="csl-right-inline">Ibrahim AS, Gebremariam T, Fu Y, et al. <a href="https://doi.org/10.1128/AAC.01458-07">Combination echinocandin-polyene treatment of murine mucormycosis</a>. Antimicrobial agents and chemotherapy [Internet]. 2008;52(4):15561558.</div>
</div>
<div id="ref-gebremariam2022" class="csl-entry" role="listitem">
<div class="csl-left-margin">[29] </div><div class="csl-right-inline">Gebremariam T, Gu Y, Alkhazraji S, et al. <a href="https://doi.org/10.1128/aac.00380-22">The Combination Treatment of Fosmanogepix and Liposomal Amphotericin B Is Superior to Monotherapy in Treating Experimental Invasive Mold Infections</a>. Antimicrobial Agents and Chemotherapy. 2022;66(7):e0038022.</div>
</div>
<div id="ref-gu2023" class="csl-entry" role="listitem">
<div class="csl-left-margin">[30] </div><div class="csl-right-inline">Gu Y, Gebremariam T, Alkhazraji S, et al. <a href="https://doi.org/10.1101/2023.11.22.568278">Efficacy of an oral lipid nanocrystal (LNC) formulation of amphotericin B (MAT2203) in the neutropenic mouse model of pulmonary mucormycosis</a>. bioRxiv: The Preprint Server for Biology. 2023;2023.11.22.568278.</div>
</div>
<div id="ref-luo2013" class="csl-entry" role="listitem">
<div class="csl-left-margin">[31] </div><div class="csl-right-inline">Luo G, Gebremariam T, Lee H, et al. <a href="https://doi.org/10.1128/AAC.00313-13">Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis</a>. Antimicrobial agents and chemotherapy [Internet]. 2013;57(7):33403347.</div>
</div>
<div id="ref-takemoto2010" class="csl-entry" role="listitem">
<div class="csl-left-margin">[32] </div><div class="csl-right-inline">Takemoto K, Yamamoto Y, Kanazawa K. <a href="https://doi.org/10.1007/s10156-010-0071-7">Comparative study of the efficacy of liposomal amphotericin B and amphotericin B deoxycholate against six species of Zygomycetes in a murine lethal infection model</a>. Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy. 2010;16(6):388–395.</div>
</div>
<div id="ref-adler-moore2017" class="csl-entry" role="listitem">
<div class="csl-left-margin">[33] </div><div class="csl-right-inline">Adler-Moore JP, Proffitt RT, Olson JA, et al. <a href="http://www.tandfonline.com/doi/abs/10.1080/08982104.2017.1327543">Tissue pharmacokinetics and pharmacodynamics of AmBisome®(l-AmBis) in uninfected and infected animals and their effects on dosing regimens</a>. Journal of liposome research [Internet]. 2017;27(3):195209.</div>
</div>
<div id="ref-groll2019c" class="csl-entry" role="listitem">
<div class="csl-left-margin">[34] </div><div class="csl-right-inline">Groll AH, Rijnders BJA, Walsh TJ, et al. <a href="https://doi.org/10.1093/cid/ciz076">Clinical pharmacokinetics, pharmacodynamics, safety and efficacy of liposomal amphotericin b</a>. Clinical Infectious Diseases [Internet]. 2019;68(Supplement<span>_</span>4):S260–S274.</div>
</div>
<div id="ref-walsh1998" class="csl-entry" role="listitem">
<div class="csl-left-margin">[35] </div><div class="csl-right-inline">Walsh TJ, Yeldandi V, McEvoy M, et al. <a href="https://www.ncbi.nlm.nih.gov/pubmed/9736569">Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients</a>. Antimicrobial agents and chemotherapy [Internet]. 1998;42(9):23912398.</div>
</div>
<div id="ref-bekersky2002a" class="csl-entry" role="listitem">
<div class="csl-left-margin">[36] </div><div class="csl-right-inline">Bekersky I, Fielding RM, Dressler DE, et al. <a href="https://www.ncbi.nlm.nih.gov/pubmed/11850269">Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate</a>. Antimicrobial agents and chemotherapy [Internet]. 2002;46(3):834840.</div>
</div>
<div id="ref-bekersky2002" class="csl-entry" role="listitem">
<div class="csl-left-margin">[37] </div><div class="csl-right-inline">Bekersky I, Fielding RM, Dressler DE, et al. <a href="http://aac.asm.org/content/46/3/828.short">Pharmacokinetics, excretion, and mass balance of liposomal amphotericin b (AmBisome) and amphotericin b deoxycholate in humans</a>. Antimicrobial agents and chemotherapy [Internet]. 2002;46(3):828833.</div>
</div>
<div id="ref-walsh2001a" class="csl-entry" role="listitem">
<div class="csl-left-margin">[38] </div><div class="csl-right-inline">Walsh TJ, Goodman JL, Pappas P, et al. <a href="https://doi.org/10.1128/AAC.45.12.3487-3496.2001">Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study</a>. Antimicrobial agents and chemotherapy [Internet]. 2001;45(12):34873496.</div>
</div>
<div id="ref-walsh2001" class="csl-entry" role="listitem">
<div class="csl-left-margin">[39] </div><div class="csl-right-inline">Walsh TJ, Goodman JL, Pappas P, et al. <a href="https://doi.org/10.1128/AAC.45.12.3487-3496.2001">Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study</a>. Antimicrobial agents and chemotherapy [Internet]. 2001;45(12):34873496.</div>
</div>
<div id="ref-lanternier2015c" class="csl-entry" role="listitem">
<div class="csl-left-margin">[40] </div><div class="csl-right-inline">Lanternier F, Poiree S, Elie C, et al. <a href="https://doi.org/10.1093/jac/dkv236">Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis</a>. Journal of Antimicrobial Chemotherapy [Internet]. 2015;70(11):3116–3123.</div>
</div>
<div id="ref-lanternier2015b" class="csl-entry" role="listitem">
<div class="csl-left-margin">[41] </div><div class="csl-right-inline">Lanternier F, Poiree S, Elie C, et al. <a href="https://doi.org/10.1093/jac/dkv236">Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis</a>. Journal of Antimicrobial Chemotherapy [Internet]. 2015;70(11):3116–3123.</div>
</div>
<div id="ref-valiante2023a" class="csl-entry" role="listitem">
<div class="csl-left-margin">[42] </div><div class="csl-right-inline">Valiante S, Elshaboury RH, Wu T, et al. <a href="https://doi.org/10.1093/ofid/ofad500.890">845. Clinical Outcomes in Patients Treated with High vs. Standard Dose Liposomal Amphotericin B for Invasive Mucormycosis</a>. Open Forum Infectious Diseases [Internet]. 2023;10(Supplement<span>_</span>2).</div>
</div>
<div id="ref-tashiro2023b" class="csl-entry" role="listitem">
<div class="csl-left-margin">[43] </div><div class="csl-right-inline">Tashiro M, Namie H, Ito Y, et al. <a href="https://doi.org/10.1093/ofid/ofad480">Prognostic Association of Liposomal Amphotericin B Doses Above 5<span></span>mg/kg/d in Mucormycosis: A Nationwide Epidemiologic and Treatment Analysis in Japan</a>. Open Forum Infectious Diseases [Internet]. 2023;10(10).</div>
</div>
<div id="ref-stover2024" class="csl-entry" role="listitem">
<div class="csl-left-margin">[44] </div><div class="csl-right-inline">Stover KR, Jordan TE, Wagner JL, et al. <a href="https://doi.org/10.7573/dic.2023-9-1">High-dose amphotericin: Yay or nay? A case series and literature review</a>. Drugs in Context [Internet]. 2024;13:1–9.</div>
</div>
<div id="ref-jeong2019f" class="csl-entry" role="listitem">
<div class="csl-left-margin">[45] </div><div class="csl-right-inline">Jeong W, Keighley C, Wolfe R, et al. <a href="https://doi.org/10.1016/j.ijantimicag.2019.01.002">Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports</a>. International Journal of Antimicrobial Agents [Internet]. 2019;53(5):589–597.</div>
</div>
<div id="ref-elitzur2021a" class="csl-entry" role="listitem">
<div class="csl-left-margin">[46] </div><div class="csl-right-inline">Elitzur S, Fischer S, Arad-Cohen N, et al. <a href="https://doi.org/10.3390/jof7030165">Disseminated Mucormycosis in Immunocompromised Children: Are New Antifungal Agents Making a Difference? A Multicenter Retrospective Study</a>. Journal of Fungi [Internet]. 2021;7(3):165.</div>
</div>
<div id="ref-risum2020b" class="csl-entry" role="listitem">
<div class="csl-left-margin">[47] </div><div class="csl-right-inline">Risum M, Helweg-Larsen J, Petersen SL, et al. <a href="https://doi.org/10.3390/jof6040268">Introduction of a Comprehensive Diagnostic and Interdisciplinary Management Approach in Haematological Patients with Mucormycosis: A Pre and Post-Intervention Analysis</a>. Journal of Fungi [Internet]. 2020;6(4):268.</div>
</div>
</div></section></div></main>
<!-- /main column -->
<script id="quarto-html-after-body" type="application/javascript">
  window.document.addEventListener("DOMContentLoaded", function (event) {
    const icon = "";
    const anchorJS = new window.AnchorJS();
    anchorJS.options = {
      placement: 'right',
      icon: icon
    };
    anchorJS.add('.anchored');
    const isCodeAnnotation = (el) => {
      for (const clz of el.classList) {
        if (clz.startsWith('code-annotation-')) {                     
          return true;
        }
      }
      return false;
    }
    const onCopySuccess = function(e) {
      // button target
      const button = e.trigger;
      // don't keep focus
      button.blur();
      // flash "checked"
      button.classList.add('code-copy-button-checked');
      var currentTitle = button.getAttribute("title");
      button.setAttribute("title", "Copied!");
      let tooltip;
      if (window.bootstrap) {
        button.setAttribute("data-bs-toggle", "tooltip");
        button.setAttribute("data-bs-placement", "left");
        button.setAttribute("data-bs-title", "Copied!");
        tooltip = new bootstrap.Tooltip(button, 
          { trigger: "manual", 
            customClass: "code-copy-button-tooltip",
            offset: [0, -8]});
        tooltip.show();    
      }
      setTimeout(function() {
        if (tooltip) {
          tooltip.hide();
          button.removeAttribute("data-bs-title");
          button.removeAttribute("data-bs-toggle");
          button.removeAttribute("data-bs-placement");
        }
        button.setAttribute("title", currentTitle);
        button.classList.remove('code-copy-button-checked');
      }, 1000);
      // clear code selection
      e.clearSelection();
    }
    const getTextToCopy = function(trigger) {
        const codeEl = trigger.previousElementSibling.cloneNode(true);
        for (const childEl of codeEl.children) {
          if (isCodeAnnotation(childEl)) {
            childEl.remove();
          }
        }
        return codeEl.innerText;
    }
    const clipboard = new window.ClipboardJS('.code-copy-button:not([data-in-quarto-modal])', {
      text: getTextToCopy
    });
    clipboard.on('success', onCopySuccess);
    if (window.document.getElementById('quarto-embedded-source-code-modal')) {
      const clipboardModal = new window.ClipboardJS('.code-copy-button[data-in-quarto-modal]', {
        text: getTextToCopy,
        container: window.document.getElementById('quarto-embedded-source-code-modal')
      });
      clipboardModal.on('success', onCopySuccess);
    }
      var localhostRegex = new RegExp(/^(?:http|https):\/\/localhost\:?[0-9]*\//);
      var mailtoRegex = new RegExp(/^mailto:/);
        var filterRegex = new RegExp('/' + window.location.host + '/');
      var isInternal = (href) => {
          return filterRegex.test(href) || localhostRegex.test(href) || mailtoRegex.test(href);
      }
      // Inspect non-navigation links and adorn them if external
     var links = window.document.querySelectorAll('a[href]:not(.nav-link):not(.navbar-brand):not(.toc-action):not(.sidebar-link):not(.sidebar-item-toggle):not(.pagination-link):not(.no-external):not([aria-hidden]):not(.dropdown-item):not(.quarto-navigation-tool):not(.about-link)');
      for (var i=0; i<links.length; i++) {
        const link = links[i];
        if (!isInternal(link.href)) {
          // undo the damage that might have been done by quarto-nav.js in the case of
          // links that we want to consider external
          if (link.dataset.originalHref !== undefined) {
            link.href = link.dataset.originalHref;
          }
        }
      }
    function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
      const config = {
        allowHTML: true,
        maxWidth: 500,
        delay: 100,
        arrow: false,
        appendTo: function(el) {
            return el.parentElement;
        },
        interactive: true,
        interactiveBorder: 10,
        theme: 'quarto',
        placement: 'bottom-start',
      };
      if (contentFn) {
        config.content = contentFn;
      }
      if (onTriggerFn) {
        config.onTrigger = onTriggerFn;
      }
      if (onUntriggerFn) {
        config.onUntrigger = onUntriggerFn;
      }
      window.tippy(el, config); 
    }
    const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
    for (var i=0; i<noterefs.length; i++) {
      const ref = noterefs[i];
      tippyHover(ref, function() {
        // use id or data attribute instead here
        let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
        try { href = new URL(href).hash; } catch {}
        const id = href.replace(/^#\/?/, "");
        const note = window.document.getElementById(id);
        if (note) {
          return note.innerHTML;
        } else {
          return "";
        }
      });
    }
    const xrefs = window.document.querySelectorAll('a.quarto-xref');
    const processXRef = (id, note) => {
      // Strip column container classes
      const stripColumnClz = (el) => {
        el.classList.remove("page-full", "page-columns");
        if (el.children) {
          for (const child of el.children) {
            stripColumnClz(child);
          }
        }
      }
      stripColumnClz(note)
      if (id === null || id.startsWith('sec-')) {
        // Special case sections, only their first couple elements
        const container = document.createElement("div");
        if (note.children && note.children.length > 2) {
          container.appendChild(note.children[0].cloneNode(true));
          for (let i = 1; i < note.children.length; i++) {
            const child = note.children[i];
            if (child.tagName === "P" && child.innerText === "") {
              continue;
            } else {
              container.appendChild(child.cloneNode(true));
              break;
            }
          }
          if (window.Quarto?.typesetMath) {
            window.Quarto.typesetMath(container);
          }
          return container.innerHTML
        } else {
          if (window.Quarto?.typesetMath) {
            window.Quarto.typesetMath(note);
          }
          return note.innerHTML;
        }
      } else {
        // Remove any anchor links if they are present
        const anchorLink = note.querySelector('a.anchorjs-link');
        if (anchorLink) {
          anchorLink.remove();
        }
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(note);
        }
        if (note.classList.contains("callout")) {
          return note.outerHTML;
        } else {
          return note.innerHTML;
        }
      }
    }
    for (var i=0; i<xrefs.length; i++) {
      const xref = xrefs[i];
      tippyHover(xref, undefined, function(instance) {
        instance.disable();
        let url = xref.getAttribute('href');
        let hash = undefined; 
        if (url.startsWith('#')) {
          hash = url;
        } else {
          try { hash = new URL(url).hash; } catch {}
        }
        if (hash) {
          const id = hash.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          if (note !== null) {
            try {
              const html = processXRef(id, note.cloneNode(true));
              instance.setContent(html);
            } finally {
              instance.enable();
              instance.show();
            }
          } else {
            // See if we can fetch this
            fetch(url.split('#')[0])
            .then(res => res.text())
            .then(html => {
              const parser = new DOMParser();
              const htmlDoc = parser.parseFromString(html, "text/html");
              const note = htmlDoc.getElementById(id);
              if (note !== null) {
                const html = processXRef(id, note);
                instance.setContent(html);
              } 
            }).finally(() => {
              instance.enable();
              instance.show();
            });
          }
        } else {
          // See if we can fetch a full url (with no hash to target)
          // This is a special case and we should probably do some content thinning / targeting
          fetch(url)
          .then(res => res.text())
          .then(html => {
            const parser = new DOMParser();
            const htmlDoc = parser.parseFromString(html, "text/html");
            const note = htmlDoc.querySelector('main.content');
            if (note !== null) {
              // This should only happen for chapter cross references
              // (since there is no id in the URL)
              // remove the first header
              if (note.children.length > 0 && note.children[0].tagName === "HEADER") {
                note.children[0].remove();
              }
              const html = processXRef(null, note);
              instance.setContent(html);
            } 
          }).finally(() => {
            instance.enable();
            instance.show();
          });
        }
      }, function(instance) {
      });
    }
        let selectedAnnoteEl;
        const selectorForAnnotation = ( cell, annotation) => {
          let cellAttr = 'data-code-cell="' + cell + '"';
          let lineAttr = 'data-code-annotation="' +  annotation + '"';
          const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
          return selector;
        }
        const selectCodeLines = (annoteEl) => {
          const doc = window.document;
          const targetCell = annoteEl.getAttribute("data-target-cell");
          const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
          const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
          const lines = annoteSpan.getAttribute("data-code-lines").split(",");
          const lineIds = lines.map((line) => {
            return targetCell + "-" + line;
          })
          let top = null;
          let height = null;
          let parent = null;
          if (lineIds.length > 0) {
              //compute the position of the single el (top and bottom and make a div)
              const el = window.document.getElementById(lineIds[0]);
              top = el.offsetTop;
              height = el.offsetHeight;
              parent = el.parentElement.parentElement;
            if (lineIds.length > 1) {
              const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
              const bottom = lastEl.offsetTop + lastEl.offsetHeight;
              height = bottom - top;
            }
            if (top !== null && height !== null && parent !== null) {
              // cook up a div (if necessary) and position it 
              let div = window.document.getElementById("code-annotation-line-highlight");
              if (div === null) {
                div = window.document.createElement("div");
                div.setAttribute("id", "code-annotation-line-highlight");
                div.style.position = 'absolute';
                parent.appendChild(div);
              }
              div.style.top = top - 2 + "px";
              div.style.height = height + 4 + "px";
              div.style.left = 0;
              let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
              if (gutterDiv === null) {
                gutterDiv = window.document.createElement("div");
                gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
                gutterDiv.style.position = 'absolute';
                const codeCell = window.document.getElementById(targetCell);
                const gutter = codeCell.querySelector('.code-annotation-gutter');
                gutter.appendChild(gutterDiv);
              }
              gutterDiv.style.top = top - 2 + "px";
              gutterDiv.style.height = height + 4 + "px";
            }
            selectedAnnoteEl = annoteEl;
          }
        };
        const unselectCodeLines = () => {
          const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
          elementsIds.forEach((elId) => {
            const div = window.document.getElementById(elId);
            if (div) {
              div.remove();
            }
          });
          selectedAnnoteEl = undefined;
        };
          // Handle positioning of the toggle
      window.addEventListener(
        "resize",
        throttle(() => {
          elRect = undefined;
          if (selectedAnnoteEl) {
            selectCodeLines(selectedAnnoteEl);
          }
        }, 10)
      );
      function throttle(fn, ms) {
      let throttle = false;
      let timer;
        return (...args) => {
          if(!throttle) { // first call gets through
              fn.apply(this, args);
              throttle = true;
          } else { // all the others get throttled
              if(timer) clearTimeout(timer); // cancel #2
              timer = setTimeout(() => {
                fn.apply(this, args);
                timer = throttle = false;
              }, ms);
          }
        };
      }
        // Attach click handler to the DT
        const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
        for (const annoteDlNode of annoteDls) {
          annoteDlNode.addEventListener('click', (event) => {
            const clickedEl = event.target;
            if (clickedEl !== selectedAnnoteEl) {
              unselectCodeLines();
              const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
              if (activeEl) {
                activeEl.classList.remove('code-annotation-active');
              }
              selectCodeLines(clickedEl);
              clickedEl.classList.add('code-annotation-active');
            } else {
              // Unselect the line
              unselectCodeLines();
              clickedEl.classList.remove('code-annotation-active');
            }
          });
        }
    const findCites = (el) => {
      const parentEl = el.parentElement;
      if (parentEl) {
        const cites = parentEl.dataset.cites;
        if (cites) {
          return {
            el,
            cites: cites.split(' ')
          };
        } else {
          return findCites(el.parentElement)
        }
      } else {
        return undefined;
      }
    };
    var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
    for (var i=0; i<bibliorefs.length; i++) {
      const ref = bibliorefs[i];
      const citeInfo = findCites(ref);
      if (citeInfo) {
        tippyHover(citeInfo.el, function() {
          var popup = window.document.createElement('div');
          citeInfo.cites.forEach(function(cite) {
            var citeDiv = window.document.createElement('div');
            citeDiv.classList.add('hanging-indent');
            citeDiv.classList.add('csl-entry');
            var biblioDiv = window.document.getElementById('ref-' + cite);
            if (biblioDiv) {
              citeDiv.innerHTML = biblioDiv.innerHTML;
            }
            popup.appendChild(citeDiv);
          });
          return popup.innerHTML;
        });
      }
    }
  });
  </script>
</div> <!-- /content -->




</body></html>